Altermune Technologies Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Altermune Technologies General Information

Description

Provider of therapeutic services to combat resistant pathogens. The company offers alphamers for the treatment of life-threatening infectious diseases.

Contact Information

Website
www.altermune.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 2875 Michelle Drive
  • Suite 300
  • Irvine, CA 92606
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Centauri Therapeutics
Vertical(s)
Life Sciences
Corporate Office
  • 2875 Michelle Drive
  • Suite 300
  • Irvine, CA 92606
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Altermune Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Altermune Technologies‘s full profile, request access.

Request a free trial

Altermune Technologies Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Altermune Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201417777-D0 Novel compounds and therapeutic uses thereof Inactive 08-Oct-2014
GB-201411150-D0 Novel aptamers and therapeutic uses thereof Inactive 23-Jun-2014
GB-201114662-D0 Chemically programmable immunity Inactive 24-Aug-2011
EP-2430033-A1 Chemically programmable immunity Inactive 05-May-2009
CA-2760774-A1 Chemically programmable immunity Inactive 05-May-2009 A61K31/7088
To view Altermune Technologies’s complete patent history, request access »

Altermune Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Altermune Technologies‘s full profile, request access.

Request a free trial

Altermune Technologies FAQs

  • When was Altermune Technologies founded?

    Altermune Technologies was founded in 2010.

  • Where is Altermune Technologies headquartered?

    Altermune Technologies is headquartered in Irvine, CA.

  • What industry is Altermune Technologies in?

    Altermune Technologies’s primary industry is Drug Discovery.

  • Is Altermune Technologies a private or public company?

    Altermune Technologies is a Private company.

  • What is Altermune Technologies’s current revenue?

    The current revenue for Altermune Technologies is .

  • How much funding has Altermune Technologies raised over time?

    Altermune Technologies has raised $7M.

  • Who are Altermune Technologies’s investors?

    Loxbridge Research has invested in Altermune Technologies.

  • When was Altermune Technologies acquired?

    Altermune Technologies was acquired on 18-Jan-2016.

  • Who acquired Altermune Technologies?

    Altermune Technologies was acquired by Centauri Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »